Amphenol Corp (APH) stock
Close on Oct 30, 2026Market cap $97.78BP/E 34.6Yield 0.47%
Earnings
Amphenol's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Amphenol's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Jan 27, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 28, 2026during market hours | $10.20B | +64.5% | $0.79 | $0.80 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 29, 2026during market hours | $8.80B | +54.4% | $1.37 | $1.35 | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 29, 2026before the open | $7.60B | +58.3% | $0.72 | $1.06 | Release |
| Q4 FY2025ended Dec 31, 2025 | Jan 28, 2026before the open | $6.40B | +48.8% | $0.93 | $0.97 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 22, 2025before the open | $6.20B | +53.5% | $0.97 | $0.93 | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 23, 2025during market hours | $5.70B | +57.9% | $0.86 | $0.81 | Release |
| Q1 FY2025ended Mar 31, 2025 | Apr 23, 2025before the open | $4.80B | +47.2% | $0.58 | $0.63 | Release |
| Q4 FY2024ended Dec 31, 2024 | Jan 22, 2025during market hours | $4.30B | +29.1% | $0.59 | $0.55 | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 23, 2024during market hours | $4.04B | +26.3% | $0.48 | $0.50 | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 24, 2024during market hours | $3.61B | +18.2% | $0.41 | $0.44 | Release |
| Q1 FY2024ended Mar 31, 2024 | Apr 24, 2024during market hours | $3.26B | +9.6% | $0.87 | $0.80 | Release |
| Q4 FY2023ended Dec 31, 2023 | Jan 24, 2024during market hours | $3.33B | +2.8% | $0.83 | $0.82 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 25, 2023during market hours | $3.20B | -2.9% | $0.83 | $0.78 | Release |
| Q2 FY2023ended Jun 30, 2023 | Jul 26, 2023during market hours | $3.05B | -2.6% | $0.74 | $0.72 | Release |
| Q1 FY2023ended Mar 31, 2023 | Apr 26, 2023during market hours | $2.97B | +0.7% | $0.71 | $0.69 | Release |
| Q4 FY2022ended Dec 31, 2022 | Jan 25, 2023during market hours | $3.24B | +7.0% | $0.82 | $0.78 | Release |
| Q3 FY2022ended Sep 30, 2022 | Oct 26, 2022during market hours | $3.30B | +16.9% | $0.80 | $0.80 | Release |
| Q2 FY2022ended Jun 30, 2022 | Jul 27, 2022during market hours | $3.14B | – | $0.76 | $0.75 | Release |
| Q1 FY2022ended Mar 31, 2022 | Apr 27, 2022during market hours | $2.95B | – | $0.68 | $0.67 | Release |
| Q4 FY2021ended Dec 31, 2021 | Jan 26, 2022during market hours | $3.03B | – | $0.72 | $0.70 | Release |
| Q3 FY2021ended Sep 30, 2021 | Oct 27, 2021during market hours | $2.82B | – | $0.67 | $0.65 | Release |
| Q2 FY2021ended Jun 30, 2021 | Jul 28, 2021during market hours | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | Apr 28, 2021during market hours | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Jan 27, 2021during market hours | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Oct 21, 2020during market hours | – | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Amphenol's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| sales | Q4 FY2026 | $10.30B – $10.50B | – | New | Oct 28, 2026 |
| Adjusted Diluted EPSnon-GAAP | Q4 FY2026 | $0.81 – $0.83 | – | New | Oct 28, 2026 |
| sales | FY2026 | $36.90B – $37.10B | – | New | Oct 28, 2026 |
| Adjusted Diluted EPSnon-GAAP | FY2026 | $2.82 – $2.84 | – | New | Oct 28, 2026 |
Guidance vs results
The last range Amphenol gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q3 FY2026 | Adjusted Diluted EPS | $1.40 – $1.42 | $0.80 | Below range |
| Q3 FY2026 | Revenue | $9.30B – $9.40B | $10.20B | Above range |
| Q3 FY2026 | Revenue growth | +50% – +52% | +64.52% | Above range |
| Q2 FY2026 | Adjusted Diluted EPS | $1.14 – $1.16 | $1.35 | Above range |
| Q2 FY2026 | Revenue | $8.10B – $8.20B | $8.80B | Above range |
| Q1 FY2026 | Adjusted Diluted EPS | $0.91 – $0.93 | $1.06 | Above range |
| Q1 FY2026 | Revenue | $6.90B – $7.00B | $7.60B | Above range |
| FY2025 | Adjusted Diluted EPS | $3.26 – $3.28 | $3.34Σ4Q | Above range |
| FY2025 | Revenue | $22.66B – $22.76B | $23.10BΣ4Q | Above range |
| Q4 FY2025 | Adjusted Diluted EPS | $0.89 – $0.91 | $0.97 | Above range |
| Q4 FY2025 | Revenue | $6.00B – $6.10B | $6.40B | Above range |
| Q3 FY2025 | Adjusted Diluted EPS | $0.77 – $0.79 | $0.93 | Above range |
| Q3 FY2025 | Revenue | $5.40B – $5.50B | $6.20B | Above range |
| Q2 FY2025 | Adjusted Diluted EPS | $0.64 – $0.66 | $0.81 | Above range |
| Q2 FY2025 | Revenue | $4.90B – $5.00B | $5.70B | Above range |
| Q2 FY2025 | Revenue growth | +36% – +39% | +57.89% | Above range |
| Q1 FY2025 | Adjusted Diluted EPS | $0.49 – $0.51 | $0.63 | Above range |
| Q1 FY2025 | Revenue | $4.00B – $4.10B | $4.80B | Above range |
| Q4 FY2024 | Adjusted Diluted EPS | $0.48 – $0.50 | $0.55 | Above range |
| Q4 FY2024 | Revenue | $3.95B – $4.05B | $4.30B | Above range |
| Q4 FY2024 | Revenue growth | +19% – +22% | +29.13% | Above range |
| Q3 FY2024 | Adjusted Diluted EPS | $0.43 – $0.45 | $0.50 | Above range |
| Q3 FY2024 | Revenue | $3.70B – $3.80B | $4.04B | Above range |
| Q2 FY2024 | Adjusted Diluted EPS | $0.79 – $0.81 | $0.44 | Below range |
| Q2 FY2024 | Revenue | $3.24B – $3.30B | $3.61B | Above range |
| Q1 FY2024 | Adjusted Diluted EPS | $0.71 – $0.73 | $0.80 | Above range |
| Q1 FY2024 | Revenue | $3.04B – $3.10B | $3.26B | Above range |
| Q4 FY2023 | Adjusted Diluted EPS | $0.75 – $0.77 | $0.82 | Above range |
| Q4 FY2023 | Revenue | $3.09B – $3.15B | $3.33B | Above range |
| Q3 FY2023 | Adjusted Diluted EPS | $0.72 – $0.74 | $0.78 | Above range |
| Q3 FY2023 | Revenue | $3.04B – $3.10B | $3.20B | Above range |
| Q2 FY2023 | Adjusted Diluted EPS | $0.66 – $0.68 | $0.72 | Above range |
| Q2 FY2023 | Revenue | $2.89B – $2.95B | $3.05B | Above range |
| Q1 FY2023 | Adjusted Diluted EPS | $0.65 – $0.67 | $0.69 | Above range |
| Q1 FY2023 | Revenue | $2.84B – $2.90B | $2.97B | Above range |
| Q4 FY2022 | Adjusted Diluted EPS | $0.73 – $0.75 | $0.78 | Above range |
| Q4 FY2022 | Revenue | $3.09B – $3.15B | $3.24B | Above range |
| Q3 FY2022 | Adjusted Diluted EPS | $0.73 – $0.75 | $0.80 | Above range |
| Q3 FY2022 | Revenue | $3.04B – $3.10B | $3.30B | Above range |
| Q2 FY2022 | Adjusted Diluted EPS | $0.66 – $0.68 | $0.75 | Above range |
| Q2 FY2022 | Revenue | $2.89B – $2.95B | $3.14B | Above range |
| Q1 FY2022 | Adjusted Diluted EPS | $0.59 – $0.61 | $0.67 | Above range |
| Q1 FY2022 | Revenue | $2.69B – $2.75B | $2.95B | Above range |
| Q4 FY2021 | Adjusted Diluted EPS | $0.61 – $0.63 | $0.70 | Above range |
| Q4 FY2021 | Revenue | $2.69B – $2.75B | $3.03B | Above range |
Guidance history
Every forecast Amphenol put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 28, 2026 | Adjusted Diluted EPS | Q4 FY2026 | $0.81 – $0.83 | New |
| Oct 28, 2026 | Adjusted Diluted EPS | FY2026 | $2.82 – $2.84 | New |
| Oct 28, 2026 | sales | Q4 FY2026 | $10.30B – $10.50B | New |
| Oct 28, 2026 | sales | FY2026 | $36.90B – $37.10B | New |
| Jul 29, 2026 | Adjusted Diluted EPS increase from the third quarter of 2025 | Q3 FY2026 | +51% – +53% | New |
| Jul 29, 2026 | Adjusted Diluted EPS | Q3 FY2026 | $1.40 – $1.42 | New |
| Jul 29, 2026 | sales increase over the prior year quarter | Q3 FY2026 | +50% – +52% | New |
| Jul 29, 2026 | sales | Q3 FY2026 | $9.30B – $9.40B | New |
| Apr 29, 2026 | Adjusted Diluted EPS | Q2 FY2026 | $1.14 – $1.16 | New |
| Apr 29, 2026 | sales | Q2 FY2026 | $8.10B – $8.20B | New |
| Jan 28, 2026 | Adjusted Diluted EPS | Q1 FY2026 | $0.91 – $0.93 | New |
| Jan 28, 2026 | sales | Q1 FY2026 | $6.90B – $7.00B | New |
| Oct 22, 2025 | Adjusted Diluted EPS | FY2025 | $3.26 – $3.28 | New |
| Oct 22, 2025 | Adjusted Diluted EPS | Q4 FY2025 | $0.89 – $0.91 | New |
| Oct 22, 2025 | sales | FY2025 | $22.66B – $22.76B | New |
| Oct 22, 2025 | sales | Q4 FY2025 | $6.00B – $6.10B | New |
| Jul 23, 2025 | Adjusted Diluted EPS | Q3 FY2025 | $0.77 – $0.79 | New |
| Jul 23, 2025 | sales | Q3 FY2025 | $5.40B – $5.50B | New |
| Apr 23, 2025 | increase from the second quarter of 2024 | Q2 FY2025 | +45% – +50% | New |
| Apr 23, 2025 | Adjusted Diluted EPS | Q2 FY2025 | $0.64 – $0.66 | New |
| Apr 23, 2025 | increase over the prior year quarter | Q2 FY2025 | +36% – +39% | New |
| Apr 23, 2025 | sales | Q2 FY2025 | $4.90B – $5.00B | New |
| Jan 22, 2025 | Adjusted Diluted EPS | Q1 FY2025 | $0.49 – $0.51 | New |
| Jan 22, 2025 | sales | Q1 FY2025 | $4.00B – $4.10B | New |
| Oct 23, 2024 | Adjusted Diluted EPS increase | Q4 FY2024 | +17% – +22% | New |
| Oct 23, 2024 | Adjusted Diluted EPS | Q4 FY2024 | $0.48 – $0.50 | New |
| Oct 23, 2024 | Adjusted Diluted EPS increase | FY2024 | +21% – +22% | New |
| Oct 23, 2024 | Adjusted Diluted EPS | FY2024 | $1.82 – $1.84 | New |
| Oct 23, 2024 | sales increase | Q4 FY2024 | +19% – +22% | New |
| Oct 23, 2024 | sales | Q4 FY2024 | $3.95B – $4.05B | New |
| Oct 23, 2024 | sales increase | FY2024 | +18% – +19% | New |
| Oct 23, 2024 | sales | FY2024 | $14.85B – $14.95B | New |
| Jul 24, 2024 | Adjusted Diluted EPS | Q3 FY2024 | $0.43 – $0.45 | New |
| Jul 24, 2024 | sales | Q3 FY2024 | $3.70B – $3.80B | New |
| Apr 24, 2024 | Adjusted Diluted EPS | Q2 FY2024 | $0.79 – $0.81 | New |
| Apr 24, 2024 | sales | Q2 FY2024 | $3.24B – $3.30B | New |
| Jan 24, 2024 | Adjusted Diluted EPS | Q1 FY2024 | $0.71 – $0.73 | New |
| Jan 24, 2024 | sales | Q1 FY2024 | $3.04B – $3.10B | New |
| Oct 25, 2023 | Adjusted Diluted EPS | Q4 FY2023 | $0.75 – $0.77 | New |
| Oct 25, 2023 | Adjusted Diluted EPS | FY2023 | $2.94 – $2.96 | New |
| Oct 25, 2023 | sales | Q4 FY2023 | $3.09B – $3.15B | New |
| Oct 25, 2023 | sales | FY2023 | $12.32B – $12.38B | New |
| Jul 26, 2023 | Adjusted Diluted EPS | Q3 FY2023 | $0.72 – $0.74 | New |
| Jul 26, 2023 | sales | Q3 FY2023 | $3.04B – $3.10B | New |
| Apr 26, 2023 | Adjusted Diluted EPS | Q2 FY2023 | $0.66 – $0.68 | New |
| Apr 26, 2023 | sales | Q2 FY2023 | $2.89B – $2.95B | New |
| Jan 25, 2023 | Adjusted Diluted EPS | Q1 FY2023 | $0.65 – $0.67 | New |
| Jan 25, 2023 | sales | Q1 FY2023 | $2.84B – $2.90B | New |
| Oct 26, 2022 | Adjusted Diluted EPS | Q4 FY2022 | $0.73 – $0.75 | New |
| Oct 26, 2022 | Adjusted Diluted EPS | FY2022 | $2.95 – $2.97 | New |
| Oct 26, 2022 | sales | Q4 FY2022 | $3.09B – $3.15B | New |
| Oct 26, 2022 | sales | FY2022 | $12.47B – $12.53B | New |
| Jul 27, 2022 | Adjusted Diluted EPS | Q3 FY2022 | $0.73 – $0.75 | New |
| Jul 27, 2022 | sales | Q3 FY2022 | $3.04B – $3.10B | New |
| Apr 27, 2022 | Adjusted Diluted EPS | Q2 FY2022 | $0.66 – $0.68 | New |
| Apr 27, 2022 | sales | Q2 FY2022 | $2.89B – $2.95B | New |
| Jan 26, 2022 | Adjusted Diluted EPS | Q1 FY2022 | $0.59 – $0.61 | New |
| Jan 26, 2022 | sales | Q1 FY2022 | $2.69B – $2.75B | New |
| Oct 27, 2021 | Adjusted Diluted EPS | Q4 FY2021 | $0.61 – $0.63 | New |
| Oct 27, 2021 | Adjusted Diluted EPS | FY2021 | $2.39 – $2.41 | New |
| Oct 27, 2021 | sales | Q4 FY2021 | $2.69B – $2.75B | New |
| Oct 27, 2021 | sales | FY2021 | $10.54B – $10.60B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Amphenol filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- News
- Results
- News
- Results
- Update
- Update
- Update
- News
- Update
- Results
- Update
- Update
- News
- Results